Fox News
Database study hints diabetes drug cuts Alzheimer's risk
Fox News
A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away. Earlier studies
German database study hints diabetes drug cuts Alzheimer's riskReuters
Diabetes Drug Shows Slight Effect on Dementia in German StudyBusinessweek
Alzheimer's Disease, Dementia Risk can Be Decreased By Diabetes Drug WallStreet OTC

all 19 news articles »

diabetes – Google News

Diabetes Drug May Spur Weight Loss in Obese People
WebMD
"Liraglutide, an injection treatment already approved for diabetes treatment, can help reduce body weight in people with obesity when used at a higher dose than is usually used in diabetes," said lead researcher Dr. John Wilding, head of the department
Diabetes Drug May Spur Weight Loss in Obese NondiabeticsPhilly.com
Diabetes Medication Liraglutide May Be Useful For Weight ManagementMedical Research News and Interviews_ MedicalResearch.com

all 7 news articles »

diabetes – Google News


Harvard Gazette
Potential New Drug for Diabetes
MIT Technology Review
Researchers have long known that the body carries an enzyme that breaks down insulin inside cells and helps regulate the body's response to sugars—a process that goes awry in type 2 diabetes. Genetic studies have shown that people with type 2 diabetes …
Harvard researchers discover new treatment for diabetesBoston Globe
Strategy for diabetes treatmentHarvard Gazette
Study Points to Potential New Treatment Approach for DiabetesHealthline
Nature.com -Philly.com
all 22 news articles »

diabetes – Google News


Updated News
Lilly's diabetes drug better than Sanofi's in late-stage trials
Reuters
(Reuters) – Eli Lilly and Co said its type 2 diabetes drug was more effective than Sanofi SA's approved drug Lantus in reducing patients' blood sugar levels in three late-stage trials. Lilly said while the main goal of the trials was to show that the
Lilly draws flak after touting PhIII diabetes success for Lantus rivalFierceBiotech
Lilly's Basal Insulin Peglispro Shows Superiority in HbA1c Reduction Compared MarketWatch

all 21 news articles »

diabetes – Google News

New Weight Loss Formula: Popular Diabetes Drug Melts Pounds, Studies Show
Forbes
If the FDA says yes, a major new weight loss drug may hit the market this year. A high-dose formulation of liraglutide, the popular popular diabetes drug from Novo Nordisk Novo Nordiskmelts up to 10 percent of body mass, studies show. Liraglutide

diabetes – Google News


Science Recorder
FDA Approves New Type 2 Diabetes Drug
WebMD
TUESDAY, April 15, 2014 (HealthDay News) — Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum. The FDA described Tanzeum …
FDA approves Tanzeum to treat type 2 diabetesFox News
GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum Wall Street Journal
GlaxoSmithKline wins an FDA nod for its GLP-1 diabetes drug albiglutideFierceBiotech
Kansas City Star -The News Journal
all 85 news articles »

diabetes – Google News


Economic Times
Lexicon Pharma's diabetes drug successful in mid-stage study
Yahoo News
(Reuters) – Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes reduced the use of insulin at meal times in a mid-stage study of patients with type 1 diabetes, sending the company's shares up as much as 17 percent. Lexicon said the
Lexicon's Type 1 Diabetes Trial Gets Positive ResultsDrug Discovery & Development

all 24 news articles »

diabetes – Google News

$ 6 Billion Jury Award Over Diabetes Drug
ABC News (blog)
Takeda Pharmaceuticals, Japan's biggest drug-maker, has been hit with $ 6 billion in punitive damages for hiding a possible link between a best-selling diabetes drug and a patient's bladder cancer. The fight is over Actos. Eli Lilly, which marketed the

and more »

diabetes – Google News


Legal Examiner
Takeda Loses First Federal Trial Over Actos Diabetes Drug
Bloomberg
Takeda, Asia's largest drugmaker, faces the Actos claims after it scrapped development of another diabetes drug this year when research linked it to liver damage. More than 2,700 Actos suits have been consolidated before U.S. District Judge Rebecca …
Takeda Jury Told of 'Reckless' Handling of Diabetes Drug (1)Businessweek
Billion-Dollar Lawsuit Against Actos Resumes TodayDrugWatch.com
Actos Bellwether Trial: $ 9 Billion Verdict for PlaintiffsLegal Examiner

all 9 news articles »

diabetes – Google News


CNBC.com
FDA advisers back MannKind's inhaled diabetes drug
CNBC.com
U.S. health advisers on Tuesday recommended approval of MannKind's inhaled diabetes drug, and said the experimental treatment could help some patients, especially those wary of needles typically used with traditional insulin therapy. Shares of Mannkind …
FDA Panel Backs Inhaled, Injection-Free Diabetes DrugHuffington Post
US FDA advisers back MannKind's inhaled diabetes drugReuters
MannKind shares soar on FDA panel's support of diabetes drugLos Angeles Times
Refinery29 -Drug Discovery & Development
all 155 news articles »

diabetes – Google News